Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04891393 · ClinicalTrials.gov registry record · NA
The Effects of Caffeine on Human Spinal Motoneurons
A NA study, sponsored by Temple University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04891393 is a NA study that has completed, run by Temple University. The registered enrollment target is 20 participants.
The verdict
NCT04891393, a NA study, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study evaluates the effects of orally ingested, commercially available, coffee (3 mg/kg of caffeine) on the excitability of human spinal motoneurons of the lower leg.
Interventions
- DIETARY_SUPPLEMENT Coffee
- DIETARY_SUPPLEMENT Decaffeinated coffee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2022-03-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04891393
The ClinicalTrials.gov registry entry for NCT04891393 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Coffee is the first listed.
NCT04891393 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04891393 about?
NCT04891393 is a clinical study titled "The Effects of Caffeine on Human Spinal Motoneurons". This study evaluates the effects of orally ingested, commercially available, coffee (3 mg/kg of caffeine) on the excitability of human spinal motoneurons of the lower leg.
What is the current status of trial NCT04891393?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-06-01. Estimated completion is 2022-03-28.
What interventions are being tested in trial NCT04891393?
The interventions under investigation include: Coffee (DIETARY_SUPPLEMENT), Decaffeinated coffee (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04891393?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.